At a glance
- Originator Nippon Chemiphar
- Developer Hitachi Chemical; Nippon Chemiphar; Nonindustrial source
- Class Anti-ischaemics; Antiarrhythmics; Antineoplastics; Piperazines; Small molecules
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Arrhythmias; Cancer; Ischaemic heart disorders